Pro-Pharmaceuticals (PRW) Announces FDA Approves IND For Use of DAVANAT
Tweet Send to a Friend
Pro-Pharmaceuticals, Inc. (Amex: PRW) announced that the FDA has granted an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


